Investor Relations

Latest Financial Results

Q3 2020

Quarter Ended Sep 30, 2020

Latest Annual Filing

Fiscal Year Ended Dec 31, 2019

View Filing

Stock Information

Company Overview

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.

Download Corporate Presentation

Investor Contact Information

Company

Ocuphire Pharma, Inc.
37000 Grand River Ave., Suite 120
Farmington Hills, MI 48335
T: 248-681-9815
ir@ocuphire.com

Investor Relations

LifeSci Advisors
250 West 55th Street, Suite 3401
New York, NY 10019
T: 646-889-1200
cdavis@lifesciadvisors.com

Transfer Agent

Olde Monmouth Stock Transfer Co., Inc.
200 Memorial Parkway
Atlantic Highlands, NJ 07716
T: 732-872-2727